European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.25% to 1,337.43 on the S&P Europe Select ADR Index, which is down 1.5% for the week.
From continental Europe, the gainers were led by financial services companies ING (ING) and Banco Bilbao Vizcaya Argentaria (BBVA), which rose 1.3% and 0.8% respectively. They were followed by financial services company Banco Santander (SAN) and telecommunications company Ericsson (ERIC), which were up 0.7% and 0.5% respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm Evaxion Biotech (EVAX), which fell 11.6% and 9.1% respectively. They were followed by furniture maker Natuzzi (NTZ) and 3D printer company Materialise (MTLS), which lost 11.4% and 5.2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and alcoholic beverage company Diageo (DEO), which increased 4.2% and 1.8% respectively. They were followed by biopharmaceutical company Verona Pharma (VRNA) and biopharmaceutical company NuCana (NCNA), which advanced 0.9% and 0.7% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Adaptimmune Therapeutics (ADAP), which tumbled 33.1% and 11.5% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and TC Biopharm (TCBP), which dropped 4.8% and 3.3% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。